BioMADE Plans Major Investment in Minnesota and New Facility in California
Two exciting facilities projects are in the works for BioMADE. The institute announced Maple Grove as the Minnesota site in its national network of bioindustrial manufacturing infrastructure. In addition, BioMADE has reached an agreement with Lygos, a pioneering sustainable specialty chemicals company, to transition its pilot-scale biomanufacturing infrastructure into a nationally available, multi-user facility in Hayward, California. Both sites will help expand domestic bioindustrial manufacturing capabilities, strengthen national security, and secure domestic supply chains for needed materials.
|